CARE BEYOND THE CLINIC
Respiri is leading the way in the development of innovative eHealth solutions that aim to improve the management of chronic and costly respiratory disorders such as asthma.
READ MORE
ASTHMA CARE BEYOND THE CLINIC
Introducing wheezo™, a new innovative asthma management tool. wheezo is an eHealth app combined with a simple, easy to use, handheld device. wheezo records breathing over 30 seconds and analyses the recording for wheeze. The engaging app also allows users to track other important asthma symptoms, triggers, medication usage, location specific weather and environmental factors (pollen, pollution, air quality).
Respiri unveils promising wheezo clinical study results
Preliminary results of a clinical study involving the wheezo asthma management platform made by eHealth technology developer Respiri (ASX: RSH) has shown the device is capable of accurately detecting the presence or absence of wheeze in patients with chronic respiratory ailments.
Respiri clinical trial shows ‘substantial agreement’ with doctor stethoscope test for asthma detection
Special Report: Respiri remains on track to commercialise its wheezo™ asthma detection device before the end of the year.
eHealth company Respiri (ASX:RSH) has continued its run of positive news flow, with the release of new clinical trial data this morning.
Respiri catches a screamer with Carlton AFLW deal
Ehealth business Respiri (ASX:RSH) has taken its biggest mark yet for 2021, signing on with the Carlton Football Club’s AFLW team for the upcoming season.
The partnership announcement will see Respiri’s wheezo device and software-as-a-service (SaaS) monitoring system supported by Carlton’s AFLW team to bring awareness of the importance of asthma management to the forefront of the community.
Respiri teams up with Carlton Football Club to promote wheezo device
A day after publishing its full year accounts, eHealth company Respiri (ASX: RSH) has tentatively set foot in Australian rules football courtesy of a partnership with Carlton Football Club AFLW, commencing from next season.
RESPIRI PARTNERS
Carlton Football Club AFLW team
Respiri is excited to announce its partnership with the Carlton Football Club AFLW for 2021 Season. The partnership announcement will see wheezo supported by the Carlton Football Club AFLW team and bring awareness of the importance of asthma management to the forefront of the community.
Australian Patients Association
Respiri recently announced their partnership with Australian Patients Association (APA) to support patients living with asthma through Respiri’s wheezo Experiential Program. The APA is connected with 1.1 million Australian patients and 15,000 Health Care Practitioners.
MICHAEL CLARKE
Respiri’s first brand ambassador. Hear from the former
Australian Cricket Captain on why he’s partnered with
Respiri to help bring wheezo to market.
JOIN OUR NEWSLETTER
Be the first to hear of Respiri’s latest news and subscribe to the bi-monthly newsletter here.